Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients
Abstract Background: Chronic kidney disease (CKD) patients have a high burden of atheromatous cardiovascular disease (ASCVD) not fully explained by traditional



